Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026)

Adaptin Bio (APTN) has 3 years of Other Non Operating Income data on file, last reported at $326345.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 5270.23% year-over-year to $326345.0; the trailing twelve-month figure through Mar 2026 stood at $659002.0 (up 428.33% YoY), and the FY2025 full-year result was $326345.0, up 267.75% from the prior year.
• Other Non Operating Income retreated to $326345.0 in Q1 2026, from $332657.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $332657.0 in Q3 2025 to a low of -$185782.0 in Q4 2024.
• A 3-year average of $65450.4 and a median of -$2373.0 in 2024 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 5423.36% in 2025, while the deepest fall reached 4645.86% in 2025.
• Tracing APTN's Other Non Operating Income over 3 years: stood at -$185782.0 in 2024, then soared by 279.06% to $332657.0 in 2025, then decreased by 1.9% to $326345.0 in 2026.
• Business Quant data shows APTN's Other Non Operating Income at $326345.0 in Q1 2026, $332657.0 in Q3 2025, and -$6312.0 in Q1 2025.